Does Adjuvant Immune Checkpoint Inhibition Therapy Have a Future in Operable Bladder Cancer? Coca Membribes S, Powles T. Eur Urol Focus 2025 Dec 15:S2405-4569(25)00370.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Coca Membribes S, Powles T. Does Adjuvant Immune Checkpoint Inhibition Therapy Have a Future in Operable Bladder Cancer? Eur Urol Focus 2025 Dec 15:S2405-4569(25)00370.
PMID: 41402157